FDA Approved: FYCOMPA — Supplemental Application (Eisai Inc.)

View source ↗

Summary

The FDA approved a supplemental application for FYCOMPA (perampanel) submitted by Eisai Inc. The approval updates the drug’s labeling/indications for epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Fycompa (perampanel)

Snippet

SUPPL AP for FYCOMPA (PERAMPANEL)